Aanjaneya Lifecare is currently trading at Rs 481.10, up by 2.95 points or 0.62% from its previous closing of Rs 478.15 on the BSE.
The scrip opened at Rs 468.00 and has touched a high and low of Rs 494.00 and Rs 464.05 respectively. So far 37785 shares were traded on the counter.
The BSE group 'B' stock of face value Rs 10 has touched a 52 week high of Rs 523.00 on 21-Sep-2011 and a 52 week low of Rs 224.00 on 27-May-2011.
Last one week high and low of the scrip stood at Rs 494.00 and Rs 393.05 respectively. The current market cap of the company is Rs 601.35 crore.
The promoters holding in the company stood at 60.24% while Institutions and Non-Institutions held 4.57% and 35.19% respectively.
Aanjaneya Lifecare, a vertically integrated pharmaceutical company with manufacturing and marketing capabilities in active pharmaceutical ingredients (APIs) with focus on anti-malarial, and finished dosage forms (FDFs) catering to various therapeutic segments has won two prestigious recognitions at 4th Annual Pharma Leadership Summit & Awards 2011.
Pharma Leaders, an international bi-monthly magazine & Indo-American Chamber of Commerce, honoured Aanjaneya Lifecare with two prestigious awards ‘Emerging Pharma Company of Year 2011’ & ‘India’s Most Technically Advanced Manufacturing Facility of the year 2011’ at a glittering ceremony in Mumbai held at Hotel Intercontinental at a gala event on December 10, 2011.
Aanjaneya Lifecare is a leading research based integrated pharmaceutical company with established research, manufacturing and marketing capabilities. It is R&D focused, has a multi product portfolio with state of the art manufacturing facilities, and is set to become a marketing conglomerate across the globe.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: